Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis
Introduction and Objectives: Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease with a high prevalence worldwide and poses serious harm to human health. There is growing evidence suggesting that the administration of specific supplements or nutrients may slow NAFLD progression. Sily...
Main Authors: | Shudi Li, Fei Duan, Suling Li, Baoping Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268123002776 |
Similar Items
-
The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose
by: Gao Sun, et al.
Published: (2019-03-01) -
Mitochondrial Dysfunction in the Transition from NASH to HCC
by: Mélissa Léveillé, et al.
Published: (2019-10-01) -
Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD)
by: Adnan Khan, et al.
Published: (2022-10-01) -
The promising role of probiotics/prebiotics/synbiotics in energy metabolism biomarkers in patients with NAFLD: A systematic review and meta-analysis
by: Shudi Li, et al.
Published: (2022-07-01) -
Liver Protein Expression in NASH Mice on a High-Fat Diet: Response to Multi-Mineral Intervention
by: James Varani, et al.
Published: (2022-05-01)